Nifty
:
22795.90
Sensex
:
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)
Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Fineotex Chemical Ltd.

Chemicals

Rating :
N/A

BSE: 533333 | NSE: FCL

NSE BSE
304.05
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  316.00
  •  319.20
  •  303.50
  •  316.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  338363
  •  1048.61
  •  456.60
  •  250.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,981.82
  • 25.20
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,925.91
  • 0.61%
  • 4.16

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.86%
  • 1.05%
  • 26.94%
  • FII
  • DII
  • Others
  • 3.36%
  • 3.61%
  • 2.18%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.76
  • 23.71
  • 15.61

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.57
  • 33.65
  • 15.82

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.95
  • 55.73
  • 29.49

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.94
  • 33.98
  • 36.18

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.61
  • 6.81
  • 8.82

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.67
  • 21.98
  • 27.13

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
10.82
13.7
17.6
P/E Ratio
32.35
25.55
19.89
Revenue
418
705
858
EBITDA
149
190
256
Net Income
120
156
212
ROA
29.4
P/Bk Ratio
10.83
ROE
30.11
24.9
21.5
FCFF
50.11
FCFF Yield
1.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
125.92
138.45
-9.05%
145.73
145.27
0.32%
141.90
132.23
7.31%
153.02
137.69
11.13%
Expenses
91.63
98.10
-6.60%
109.34
107.06
2.13%
106.65
100.70
5.91%
114.73
104.98
9.29%
EBITDA
34.29
40.35
-15.02%
36.39
38.21
-4.76%
35.25
31.53
11.80%
38.29
32.71
17.06%
EBIDTM
27.23%
29.15%
24.97%
26.30%
24.84%
23.84%
25.02%
23.76%
Other Income
4.99
4.94
1.01%
6.90
3.81
81.10%
4.88
3.64
34.07%
4.15
2.09
98.56%
Interest
0.20
0.30
-33.33%
0.22
0.26
-15.38%
0.25
0.19
31.58%
0.59
0.26
126.92%
Depreciation
2.59
1.43
81.12%
2.37
1.41
68.09%
2.25
1.33
69.17%
1.85
1.16
59.48%
PBT
36.48
43.56
-16.25%
40.70
40.35
0.87%
37.63
33.65
11.83%
40.00
33.38
19.83%
Tax
8.65
10.64
-18.70%
8.64
8.86
-2.48%
8.46
7.52
12.50%
9.53
7.38
29.13%
PAT
27.83
32.92
-15.46%
32.07
31.49
1.84%
29.18
26.13
11.67%
30.48
26.00
17.23%
PATM
22.10%
23.78%
22.00%
21.68%
20.56%
19.76%
19.92%
18.88%
EPS
2.38
2.95
-19.32%
2.75
2.83
-2.83%
2.56
2.32
10.34%
2.72
2.33
16.74%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
566.57
568.97
517.00
368.23
218.51
196.34
182.33
141.12
127.03
109.92
101.98
Net Sales Growth
2.34%
10.05%
40.40%
68.52%
11.29%
7.68%
29.20%
11.09%
15.57%
7.79%
 
Cost Of Goods Sold
346.44
334.88
325.98
222.46
132.90
116.19
109.23
79.32
68.77
58.01
62.70
Gross Profit
220.13
234.08
191.02
145.78
85.61
80.14
73.10
61.80
58.26
51.91
39.29
GP Margin
38.85%
41.14%
36.95%
39.59%
39.18%
40.82%
40.09%
43.79%
45.86%
47.23%
38.53%
Total Expenditure
422.35
420.59
404.40
297.02
177.94
161.55
147.88
111.14
97.55
82.25
85.49
Power & Fuel Cost
-
1.75
1.58
1.08
0.67
0.51
0.47
0.39
0.44
0.43
0.22
% Of Sales
-
0.31%
0.31%
0.29%
0.31%
0.26%
0.26%
0.28%
0.35%
0.39%
0.22%
Employee Cost
-
21.16
18.38
13.57
8.86
8.73
7.53
6.18
4.64
3.79
3.70
% Of Sales
-
3.72%
3.56%
3.69%
4.05%
4.45%
4.13%
4.38%
3.65%
3.45%
3.63%
Manufacturing Exp.
-
21.24
19.91
19.08
11.75
11.05
11.73
9.07
8.67
9.95
8.78
% Of Sales
-
3.73%
3.85%
5.18%
5.38%
5.63%
6.43%
6.43%
6.83%
9.05%
8.61%
General & Admin Exp.
-
15.76
13.07
14.26
8.98
10.94
7.08
4.76
5.78
5.45
4.19
% Of Sales
-
2.77%
2.53%
3.87%
4.11%
5.57%
3.88%
3.37%
4.55%
4.96%
4.11%
Selling & Distn. Exp.
-
18.62
18.84
21.91
10.04
9.82
7.69
7.57
6.30
2.58
2.21
% Of Sales
-
3.27%
3.64%
5.95%
4.59%
5.00%
4.22%
5.36%
4.96%
2.35%
2.17%
Miscellaneous Exp.
-
7.17
6.65
4.66
4.73
4.31
4.15
3.86
2.95
2.03
2.21
% Of Sales
-
1.26%
1.29%
1.27%
2.16%
2.20%
2.28%
2.74%
2.32%
1.85%
3.63%
EBITDA
144.22
148.38
112.60
71.21
40.57
34.79
34.45
29.98
29.48
27.67
16.49
EBITDA Margin
25.45%
26.08%
21.78%
19.34%
18.57%
17.72%
18.89%
21.24%
23.21%
25.17%
16.17%
Other Income
20.92
16.54
7.30
5.52
17.49
1.61
0.85
5.17
9.75
2.13
4.54
Interest
1.26
1.33
0.82
0.92
0.72
0.63
0.83
0.57
0.39
0.39
0.33
Depreciation
9.06
6.02
4.28
2.51
1.47
1.17
1.00
0.65
0.63
0.56
0.50
PBT
154.81
157.57
114.80
73.29
55.86
34.60
33.47
33.92
38.21
28.86
20.20
Tax
35.28
36.54
25.24
16.40
11.31
7.65
9.30
9.95
9.14
9.14
5.60
Tax Rate
22.79%
23.19%
21.99%
22.38%
20.25%
34.82%
27.65%
29.33%
23.92%
31.67%
27.72%
PAT
119.56
119.80
88.31
55.17
42.59
13.08
22.52
22.70
25.81
17.04
12.91
PAT before Minority Interest
118.34
121.02
89.55
56.89
44.56
14.31
24.33
23.97
29.07
19.71
14.59
Minority Interest
-1.22
-1.22
-1.24
-1.72
-1.97
-1.23
-1.81
-1.27
-3.26
-2.67
-1.68
PAT Margin
21.10%
21.06%
17.08%
14.98%
19.49%
6.66%
12.35%
16.09%
20.32%
15.50%
12.66%
PAT Growth
2.59%
35.66%
60.07%
29.54%
225.61%
-41.92%
-0.79%
-12.05%
51.47%
31.99%
 
EPS
10.43
10.45
7.71
4.81
3.72
1.14
1.97
1.98
2.25
1.49
1.13

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
447.09
348.66
262.14
209.34
169.69
158.81
135.72
112.48
91.29
76.32
Share Capital
22.15
22.15
22.15
22.15
22.26
22.26
22.26
22.26
22.46
22.46
Total Reserves
424.45
326.23
239.95
187.19
147.43
136.55
113.46
90.22
68.83
53.86
Non-Current Liabilities
5.18
3.19
2.02
1.25
0.01
0.78
0.48
-0.07
-0.48
-0.47
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.10
0.22
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.35
0.03
0.14
0.06
0.06
0.05
0.04
0.07
0.00
0.00
Current Liabilities
89.41
63.84
68.07
49.62
31.32
29.47
18.56
20.06
18.08
19.08
Trade Payables
72.81
47.36
58.77
36.84
23.38
20.90
10.86
15.48
13.04
14.05
Other Current Liabilities
10.94
8.84
7.17
9.22
4.85
6.31
3.05
3.44
0.51
1.16
Short Term Borrowings
5.19
7.28
1.88
3.41
2.84
1.98
4.42
1.07
3.05
1.02
Short Term Provisions
0.47
0.36
0.25
0.15
0.24
0.28
0.23
0.07
1.48
2.84
Total Liabilities
548.15
422.70
339.48
266.96
207.31
194.74
160.95
139.66
113.71
100.30
Net Block
137.13
94.94
80.10
55.62
36.82
32.19
25.36
23.40
19.25
17.76
Gross Block
154.68
106.56
87.48
60.49
40.27
34.48
26.64
25.76
22.37
20.30
Accumulated Depreciation
17.54
11.62
7.38
4.87
3.45
2.28
1.28
2.36
3.11
2.53
Non Current Assets
262.31
198.77
107.69
101.33
91.92
86.44
88.76
80.99
64.19
55.11
Capital Work in Progress
0.00
0.36
0.00
4.59
0.63
0.14
0.12
0.00
0.00
0.03
Non Current Investment
107.95
89.33
17.31
35.30
47.76
47.00
56.98
50.80
38.98
29.30
Long Term Loans & Adv.
12.97
8.85
6.19
5.64
6.57
6.98
6.17
6.78
5.96
8.02
Other Non Current Assets
0.32
1.35
0.15
0.17
0.14
0.13
0.13
0.02
0.00
0.00
Current Assets
278.64
216.73
224.60
165.63
115.39
108.30
72.18
58.67
49.52
45.20
Current Investments
38.76
0.00
0.00
0.86
8.50
4.94
1.56
0.00
0.00
0.00
Inventories
50.11
47.29
59.59
28.75
21.09
25.09
21.10
13.14
11.47
10.41
Sundry Debtors
138.82
101.40
110.89
82.67
53.85
49.13
27.92
29.25
25.39
22.29
Cash & Bank
39.92
59.57
38.06
33.91
17.93
14.74
8.01
13.12
9.46
10.01
Other Current Assets
11.04
3.14
2.00
10.38
14.03
14.40
13.60
3.17
3.20
2.49
Short Term Loans & Adv.
6.11
5.32
14.06
9.05
1.48
1.89
3.73
2.36
3.07
2.13
Net Current Assets
189.23
152.88
156.52
116.01
84.07
78.82
53.62
38.61
31.44
26.12
Total Assets
540.95
415.50
332.29
266.96
207.31
194.74
160.94
139.66
113.71
100.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
97.38
107.27
13.38
9.20
28.36
12.02
6.34
19.12
13.62
13.30
PBT
157.57
114.80
73.29
55.86
21.96
33.63
33.92
38.21
28.86
20.20
Adjustment
-7.57
0.90
-0.66
-13.25
13.73
0.79
-3.60
-7.65
-0.87
-3.00
Changes in Working Capital
-13.70
17.93
-42.16
-23.77
0.64
-12.83
-14.80
-0.03
-4.20
0.39
Cash after chg. in Working capital
136.30
133.63
30.47
18.84
36.33
21.59
15.52
30.53
23.79
17.60
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-38.92
-26.36
-17.09
-9.65
-7.98
-9.57
-9.18
-11.41
-10.17
-4.29
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-46.85
-101.84
-0.74
-6.53
-19.01
4.18
-9.41
-10.89
-9.78
-12.40
Net Fixed Assets
-12.96
-17.18
-14.85
-22.41
-6.18
-7.65
-2.25
-2.98
-2.02
-4.22
Net Investments
-72.23
-48.71
18.90
19.12
-4.28
6.60
-7.74
-11.81
-9.85
-13.58
Others
38.34
-35.95
-4.79
-3.24
-8.55
5.23
0.58
3.90
2.09
5.40
Cash from Financing Activity
-23.91
-6.44
-5.66
-4.44
-3.88
-3.44
-3.62
-5.85
-1.46
-2.58
Net Cash Inflow / Outflow
26.62
-1.01
6.97
-1.78
5.47
12.76
-6.69
2.39
2.38
-1.68
Opening Cash & Equivalents
30.29
28.93
20.54
23.03
17.18
3.60
6.59
8.54
9.17
11.84
Closing Cash & Equivalent
56.32
30.29
28.93
20.54
23.03
17.18
3.60
7.67
8.54
8.61

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
40.32
31.46
23.67
18.90
15.25
14.27
12.19
10.11
8.13
6.80
ROA
24.93%
23.50%
18.76%
18.79%
7.12%
13.68%
15.95%
22.94%
18.42%
15.55%
ROE
30.45%
29.34%
24.13%
23.51%
8.71%
16.52%
19.31%
28.53%
23.52%
20.69%
ROCE
39.32%
37.30%
31.12%
29.35%
13.54%
22.86%
27.16%
37.14%
33.92%
28.01%
Fixed Asset Turnover
4.36
5.33
4.98
4.34
5.25
5.97
5.46
5.58
5.48
6.00
Receivable days
77.05
74.94
95.93
114.02
95.72
77.12
73.00
74.20
74.51
74.47
Inventory Days
31.24
37.73
43.79
41.63
42.92
46.22
43.71
33.42
34.19
36.81
Payable days
65.49
59.42
78.44
82.68
55.74
41.38
46.48
57.24
65.06
65.93
Cash Conversion Cycle
42.81
53.25
61.28
72.96
82.90
81.97
70.23
50.38
43.64
45.35
Total Debt/Equity
0.01
0.02
0.01
0.02
0.02
0.01
0.03
0.01
0.03
0.02
Interest Cover
119.35
140.91
80.38
78.16
35.85
41.37
60.58
98.77
75.28
62.81

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Fineotex Chemical’s arm secures government approval for mosquito control solution
    15th Feb 2025, 14:34 PM

    The company will work closely with government agencies, NGOs, and healthcare organizations to implement largescale mosquito control programs

    Read More
  • Fineotex Chemical inaugurates new office space in Mumbai
    23rd Jan 2025, 09:57 AM

    The modern workspace is designed to accommodate the company’s upcoming organic and inorganic growth

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.